Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederpharmatimes.com
PharmaTimes: News RSS
Get the latest updates from PharmaTimes: News RSS directly as they happen.
Follow now 137 followers
Latest posts
Last updated about 21 hours ago
Akiram advances trial of targeted radiotherapy for solid tumours
about 21 hours ago
Swedish biotech company Akiram Therapeutics has announced significant progress in its first...
Coya Therapeutics to progress trial of ALS treatment upon FDA approval
about 21 hours ago
The US Food and Drug Administration (FDA) has accepted an Investigational New...
Encare’s ERAS system gains Mayo Clinic qualification, strengthening global reach
2 days ago
Encare’s ERAS Interactive Audit System (EIAS) has earned qualification on the Mayo...
Johnny Cheng appointed as interim CEO of HUTCHMED
2 days ago
HUTCHMED has announced that Weiguo Su, CEO of the company, will take...
Novartis blood disorder drug shows promise in late-stage trial
3 days ago
Novartis has reported that its experimental drug ianalumab met the primary goal...
Anne White to retire as head of Lilly Neuroscience after three decades at company
3 days ago
Eli Lilly and Company has announced that Anne White, executive vice president...
ANGLE partners with Myriad Genetics to explore blood-based cancer testing
8 days ago
ANGLE has announced a collaboration with Myriad Genetics to assess whether circulating...
Friends of Cancer Research and MMS partner to improve interpretation of cancer trial survival data
8 days ago
Friends of Cancer Research has announced a new collaboration with global clinical...
Upperton Pharma Solutions awarded grant to develop oral vaccine delivery with University of Oxford
10 days ago
Upperton Pharma Solutions has been awarded funding under the first VaxHub Sustainable...
FDA grants Breakthrough Therapy Designation to lung cancer therapy
10 days ago
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation...
Ogsiveo approved in EU for treatment of desmoid tumors
11 days ago
Merck’s therapy becomes first authorised option for aggressive soft tissue tumours
Upperton and Oxford join forces to develop oral vaccine formulation
11 days ago
Project aims to improve global immunisation through needle-free delivery